Can a PET-CT scan detect skin cancer?
Generally, PET-CT can assist in evaluating the metastasis of skin cancer, but it is not commonly used for the initial diagnosis of primary skin cancer lesions. If there are concerns, it is recommended to seek medical advice promptly. The detailed analysis is as follows:

If metastasis of skin cancer is suspected, PET-CT can be helpful. By performing a whole-body scan, it can detect areas of abnormal metabolic activity throughout the body, helping determine whether cancer cells have spread to lymph nodes or other organs, thus providing valuable information for developing subsequent treatment plans. In such cases, the diagnostic value of PET-CT is relatively clear.
However, for diagnosing primary tumors on the skin surface, PET-CT is usually not the first choice. Primary skin cancer lesions often present as visible abnormalities—such as lumps or patches—on the skin's surface, which can typically be diagnosed accurately through visual inspection, dermoscopy, and pathological biopsy. PET-CT is not only more costly, but also less precise than specialized examinations in detecting small, superficial lesions. Indiscriminate use may lead to unnecessary resource consumption.
Upon noticing any skin abnormalities, individuals should first visit a dermatology department, where a physician can determine whether further testing is needed. If metastasis needs to be ruled out, PET-CT should be performed only as directed by a doctor. Definitive diagnosis must rely on pathological examination results; solely depending on imaging findings may delay proper diagnosis and treatment.